Patrick J. Omara - Net Worth and Insider Trading
Patrick J. Omara Net Worth
The estimated net worth of Patrick J. Omara is at least $163,115 dollars as of 2024-09-20. Patrick J. Omara is the VP, Business Development of CymaBay Therapeutics Inc and owns about 5,022 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $163,115. Details can be seen in Patrick J. Omara's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick J. Omara has not made any transactions after 2016-04-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick J. Omara
Patrick J. Omara Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick J. Omara owns 1 companies in total, including CymaBay Therapeutics Inc (CBAY) .
Click here to see the complete history of Patrick J. Omara’s form 4 insider trades.
Insider Ownership Summary of Patrick J. Omara
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2016-04-15 | VP & Business Development |
Patrick J. Omara Latest Holdings Summary
Patrick J. Omara currently owns a total of 1 stock. Patrick J. Omara owns 5,022 shares of CymaBay Therapeutics Inc (CBAY) as of April 15, 2016, with a value of $163,115.
Latest Holdings of Patrick J. Omara
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2016-04-15 | 5,022 | 32.48 | 163,115 |
Holding Weightings of Patrick J. Omara
Patrick J. Omara Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick J. Omara has made a total of 0 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years. The most-recent trade in CymaBay Therapeutics Inc is the acquisition of 5,000 shares on April 15, 2016, which cost Patrick J. Omara around $8,200.
Insider Trading History of Patrick J. Omara
- 1
Patrick J. Omara Trading Performance
GuruFocus tracks the stock performance after each of Patrick J. Omara's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J. Omara is 9.2%. GuruFocus also compares Patrick J. Omara's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J. Omara within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick J. Omara's insider trading performs compared to the benchmark.
Performance of Patrick J. Omara
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 43.56 | | | | | |
| Relative Return to S&P 500(%) | 45.2 | | | | | |
Patrick J. Omara Ownership Network
Patrick J. Omara Owned Company Details
What does CymaBay Therapeutics Inc do?
Who are the key executives at CymaBay Therapeutics Inc?
Patrick J. Omara is the VP & Business Development of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and General Counsel Paul T Quinlan .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Patrick J. Omara made no insider transaction in CymaBay Therapeutics Inc (CBAY). Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 171,559 shares made by Charles Mcwherter , a net sale of 93,000 shares made by Paul T Quinlan , and a net sale of 52,442 shares made by Daniel Menold .
In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 601,746 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 601,746 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Patrick J. Omara Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick J. Omara. You might contact Patrick J. Omara via mailing address: C/o Cymabay Therapeutics, Inc., 7999 Gateway Blvd., Suite 130, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
